Table 5 NAFLD score of all participants
From: Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
| Â | NAFLD cases | Controls | p value | |
|---|---|---|---|---|
NAFLD fibrosis score | Mean ± SD | − 0.785 ± 0.80 | − 3.21 ± 0.54 | < 0.001 |
F0-F2 n (%) | 7 (17.50%) | 40 (100%) | < 0.001 | |
Indeterminate n (%) | 33 (82.50%) | 0 (0.00%) | ||